nodes	percent_of_prediction	percent_of_DWPC	metapath
Gonadorelin—GNRHR—Hormone ligand-binding receptors—LHCGR—polycystic ovary syndrome	0.133	0.145	CbGpPWpGaD
Gonadorelin—GNRHR—Hormone ligand-binding receptors—FSHR—polycystic ovary syndrome	0.0976	0.106	CbGpPWpGaD
Gonadorelin—GNRHR—Hormone ligand-binding receptors—LHB—polycystic ovary syndrome	0.0849	0.0921	CbGpPWpGaD
Gonadorelin—GNRHR—Hormone ligand-binding receptors—GNRH1—polycystic ovary syndrome	0.083	0.09	CbGpPWpGaD
Gonadorelin—Cetrorelix—LHCGR—polycystic ovary syndrome	0.0418	0.534	CrCbGaD
Gonadorelin—Goserelin—LHCGR—polycystic ovary syndrome	0.0365	0.466	CrCbGaD
Gonadorelin—GNRHR—Peptide GPCRs—LHCGR—polycystic ovary syndrome	0.0269	0.0292	CbGpPWpGaD
Gonadorelin—GNRHR—GPCRs, Other—ADRA1D—polycystic ovary syndrome	0.0207	0.0224	CbGpPWpGaD
Gonadorelin—GNRHR—Peptide GPCRs—FSHR—polycystic ovary syndrome	0.0197	0.0213	CbGpPWpGaD
Gonadorelin—GNRHR—GPCRs, Other—FSHR—polycystic ovary syndrome	0.0167	0.0181	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—PTAFR—polycystic ovary syndrome	0.012	0.013	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—ADRA1D—polycystic ovary syndrome	0.0116	0.0126	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—ADRA1B—polycystic ovary syndrome	0.0113	0.0123	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PTAFR—polycystic ovary syndrome	0.0107	0.0116	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1D—polycystic ovary syndrome	0.0104	0.0113	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.0102	0.011	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1B—polycystic ovary syndrome	0.0101	0.011	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—ADRA1A—polycystic ovary syndrome	0.00857	0.0093	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.00848	0.0092	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.00848	0.0092	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—GNRH1—polycystic ovary syndrome	0.00797	0.00865	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.00793	0.00861	CbGpPWpGaD
Gonadorelin—GNRHR—GPCRs, Other—ADRB2—polycystic ovary syndrome	0.00793	0.0086	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00774	0.0084	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.0077	0.00836	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1A—polycystic ovary syndrome	0.00767	0.00832	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00749	0.00813	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—polycystic ovary syndrome	0.00713	0.00773	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00646	0.00701	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00646	0.00701	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00621	0.00673	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00604	0.00655	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00586	0.00636	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.0057	0.00619	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00568	0.00616	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00546	0.00593	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.0054	0.00586	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.00538	0.00584	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00528	0.00573	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00483	0.00524	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.00481	0.00522	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00473	0.00513	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00437	0.00474	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00432	0.00469	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00416	0.00452	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00411	0.00446	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00402	0.00436	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00397	0.00431	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00395	0.00429	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00387	0.0042	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00387	0.0042	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00385	0.00418	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00368	0.00399	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00365	0.00396	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00365	0.00396	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00359	0.0039	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00356	0.00387	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00341	0.0037	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00331	0.0036	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00331	0.0036	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00331	0.0036	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00322	0.0035	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.0031	0.00336	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00301	0.00327	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00295	0.0032	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00293	0.00318	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00293	0.00318	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00271	0.00295	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00268	0.00291	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00267	0.0029	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00266	0.00289	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00244	0.00265	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00243	0.00263	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00235	0.00255	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NPB—polycystic ovary syndrome	0.00235	0.00255	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00232	0.00252	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00227	0.00246	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00225	0.00244	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00222	0.00241	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00218	0.00236	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00214	0.00232	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00212	0.0023	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00211	0.00229	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00208	0.00226	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00208	0.00225	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00206	0.00224	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00198	0.00215	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00196	0.00212	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00196	0.00212	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00189	0.00205	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00184	0.002	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00183	0.00199	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00178	0.00193	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00173	0.00188	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00169	0.00183	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00157	0.00171	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00153	0.00166	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00143	0.00155	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—POMC—polycystic ovary syndrome	0.0014	0.00152	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00139	0.00151	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00135	0.00146	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00131	0.00142	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FST—polycystic ovary syndrome	0.00128	0.00139	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00127	0.00138	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00126	0.00137	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—LHB—polycystic ovary syndrome	0.00125	0.00135	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00122	0.00132	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00118	0.00128	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00118	0.00128	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SCT—polycystic ovary syndrome	0.00117	0.00127	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00115	0.00125	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00111	0.00121	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FGF18—polycystic ovary syndrome	0.0011	0.00119	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00109	0.00118	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.00108	0.00117	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00107	0.00116	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00101	0.0011	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GAB1—polycystic ovary syndrome	0.001	0.00108	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—INSR—polycystic ovary syndrome	0.000956	0.00104	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000908	0.000986	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000894	0.00097	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PGR—polycystic ovary syndrome	0.000885	0.000961	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000823	0.000893	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000823	0.000893	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000793	0.00086	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000785	0.000852	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000766	0.000831	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000762	0.000827	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000725	0.000786	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00072	0.000781	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PRL—polycystic ovary syndrome	0.000718	0.000779	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000692	0.000751	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000681	0.000739	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000632	0.000685	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000602	0.000653	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000591	0.000641	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000506	0.000549	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—LEP—polycystic ovary syndrome	0.000495	0.000537	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000442	0.000479	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—POMC—polycystic ovary syndrome	0.000425	0.000461	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—INS—polycystic ovary syndrome	0.000423	0.000459	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000409	0.000444	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000409	0.000444	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000389	0.000422	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000313	0.000339	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000267	0.00029	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IL6—polycystic ovary syndrome	0.000185	0.000201	CbGpPWpGaD
